Evidence map›Paper›PMID 32566135›Full record

ArticleF1000Research2020

A community proposal to integrate structural bioinformatics activities in ELIXIR (3D-Bioinfo Community).

Christine Orengo, Sameer Velankar, Shoshana Wodak, Vincent Zoete, Alexandre M J J Bonvin, Arne Elofsson, K Anton Feenstra, Dietland L Gerloff, Thomas Hamelryck, John M Hancock and 13 more

Abstract read
In one paragraph

Article in F1000Research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Christine OrengoStructural and Molecular Biology Department, University College, London, UK.
Sameer VelankarProtein Data Bank in Europe, European Molecular Biology Laboratory, European Bioinformatics Institute, Hinxton, CB10 1SD, UK.
Shoshana WodakVIB-VUB Center for Structural Biology, Brussels, Belgium.
Vincent ZoeteDepartment of Oncology, Lausanne University, Swiss Institute of Bioinformatics, Lausanne, Switzerland.
Alexandre M J J BonvinBijvoet Center, Faculty of Science - Chemistry, Utrecht University, Utrecht, 3584CH, The Netherlands.ORCID 0000-0001-7369-1322
Arne ElofssonScience for Life Laboratory, Stockholm University, Solna, S-17121, Sweden.ORCID 0000-0002-7115-9751
K Anton FeenstraDept. Computer Science, Center for Integrative Bioinformatics VU (IBIVU), Vrije Universiteit, Amsterdam, 1081 HV, The Netherlands.ORCID 0000-0001-6755-9667
Dietland L GerloffLuxembourg Centre for Systems Biomedicine, University of Luxembourg, Belvaux, L-4367, Luxembourg.
Thomas HamelryckBioinformatics center, Department of Biology, University of Copenhagen, Copenhagen, DK-2200, Denmark.
John M HancockELIXIR Hub, ELIXIR, Hinxton, UK.ORCID 0000-0003-2991-2217
Manuela Helmer-CitterichDepartment of Biology, University of Rome Tor Vergata, Rome, I-00133, Italy.
Adam HospitalInstitute for Research in Biomedicine, The Barcelona Institute of Science and Technology, Barcelona, 08028, Spain.
Modesto OrozcoInstitute for Research in Biomedicine, The Barcelona Institute of Science and Technology, Barcelona, 08028, Spain.
Anastassis PerrakisNetherlands Cancer Institute and Oncode Institute, Utrecht, The Netherlands.ORCID 0000-0002-1151-6227
Matthias RareyZBH - Center for Bioinformatics, Universität Hamburg, Hamburg, D-20146, Germany.
Claudio SoaresInstituto de Tecnologia Química e Biológica Antonio Xavier, Universidade Nova de Lisboa, Lisbon, Portugal.
Joel L SussmanDepartment of Structural Biology, Weizmann Institute of Science, Rehovot, 76100, Israel.
Janet M ThorntonEuropean Molecular Biology Laboratory, European Bioinformatics Institute, Hinxton, CB10 1SD, UK.
Pierre TufferyRessource Parisienne en Bioinformatique Structurale, Université de Paris, Paris, F-75205, France.ORCID 0000-0003-1033-9895
Gabor TusnadyMembrane Bioinformatics Research Group, Institute of Enzymology, Budapest, H-1117, Hungary.
Rikkert WierengaFBMM, Biocenter Oulu, University of Oulu, Oulu, Finland.
Tiina SalminenStructural Bioinformatics Laboratory, Åbo Akademi University, Turku, FI-20500, Finland.
Bohdan SchneiderInstitute of Biotechnology of the Czech Academy of Sciences, Vestec, CZ-25250, Czech Republic.ORCID 0000-0001-7855-3690

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Structural bioinformatics provides the scientific methods and tools to analyse, archive, validate, and present the biomolecular structure data generated by the structural biology community. It also provides an important link with the genomics community, as structural bioinformaticians also use the extensive sequence data to predict protein structures and their functional sites. A very broad and active community of structural bioinformaticians exists across Europe, and 3D-Bioinfo will establish formal platforms to address their needs and better integrate their activities and initiatives. Our mission will be to strengthen the ties with the structural biology research communities in Europe covering life sciences, as well as chemistry and physics and to bridge the gap between these researchers in order to fully realize the potential of structural bioinformatics. Our Community will also undertake dedicated educational, training and outreach efforts to facilitate this, bringing new insights and thus facilitating the development of much needed innovative applications e.g. for human health, drug and protein design. Our combined efforts will be of critical importance to keep the European research efforts competitive in this respect. Here we highlight the major European contributions to the field of structural bioinformatics, the most pressing challenges remaining and how Europe-wide interactions, enabled by ELIXIR and its platforms, will help in addressing these challenges and in coordinating structural bioinformatics resources across Europe. In particular, we present recent activities and future plans to consolidate an ELIXIR 3D-Bioinfo Community in structural bioinformatics and propose means to develop better links across the community. These include building new consortia, organising workshops to establish data standards and seeking community agreement on benchmark data sets and strategies. We also highlight existing and planned collaborations with other ELIXIR Communities and other European infrastructures, such as the structural biology community supported by Instruct-ERIC, with whom we have synergies and overlapping common interests.

Indexed as

Biological Science DisciplinesComputational BiologyEuropeGenomicsHumansProteinsProteinsbiomolecular structureELIXIRInstruct-ERICnucleic acids structureprotein structurestructural bioinformatics

Identifiers

PMID32566135
PMCPMC7284151

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.